AI brief of an SEC Form 8-K · IQVIA (IQV)
IQVIA raises 2026 guidance as Q3 revenue rises 8.0% to $4.43 billion
IQVIA reported third-quarter 2026 revenue of $4,428 million, up 8.0%, and Adjusted Diluted EPS of $3.34, up 11.3% year-over-year. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS, which is the key development for shareholders. The filing also discloses a backlog adjustment of approximately $2.1 billion tied to a review of inactive trials, which the company says does not affect 2026 guidance.
Key points
- Q3 revenue $4,428 million, up 8.0% reported and 8.6% at constant currency; GAAP diluted EPS $2.10 versus $1.93 a year earlier
- Full-year 2026 revenue guidance raised to $17,350 million to $17,500 million; Adjusted EBITDA to $4,025 million to $4,055 million
- Full-year 2026 Adjusted Diluted EPS guidance raised to $12.90 to $13.00
- Backlog adjusted by approximately $2.1 billion after review of inactive trials; R&DS contracted backlog stood at $32.6 billion as of September 30, 2026
The filing
CompanyIQVIA (IQV)
Form8-K, current report
Filed with the SECOct 27, 2026, 7:08 AM ET
Accession number0001628280-26-067406
Written by AI on Nov 7, 2026, 11:18 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.